Cargando…

Diagnostic value of 3.0T (1)H MRS with choline-containing compounds ratio (∆CCC) in primary malignant hepatic tumors

BACKGROUND: The purpose of this study was to investigate the diagnostic value of 3.0-T (1)H magnetic resonance spectroscopy ((1)H MRS) in primary malignant hepatic tumors and to compare the effects of (1)H MRS on the diagnostic accuracy of liver-occupying lesions between junior and experienced radio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li, Zhao, Xinming, Ouyang, Han, Wang, Shuang, Zhou, Chunwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994245/
https://www.ncbi.nlm.nih.gov/pubmed/27549094
http://dx.doi.org/10.1186/s40644-016-0082-4
_version_ 1782449288551333888
author Zhang, Li
Zhao, Xinming
Ouyang, Han
Wang, Shuang
Zhou, Chunwu
author_facet Zhang, Li
Zhao, Xinming
Ouyang, Han
Wang, Shuang
Zhou, Chunwu
author_sort Zhang, Li
collection PubMed
description BACKGROUND: The purpose of this study was to investigate the diagnostic value of 3.0-T (1)H magnetic resonance spectroscopy ((1)H MRS) in primary malignant hepatic tumors and to compare the effects of (1)H MRS on the diagnostic accuracy of liver-occupying lesions between junior and experienced radiologists. METHODS: This study included 50 healthy volunteers and 40 consecutive patients (50 lesions). Informed consent was obtained from each subject. Images were obtained on clinical whole-body 3.0-T MR system. Point -Resolved Spectroscopy was used to obtain the spectroscopy image. All conventional images were reviewed blindly by junior radiologist and experienced radiologist, respectively. The choline-containing compounds peak area (CCC-A) was measured with SAGE software, and the choline-containing compound ratio (∆CCC) was calculated. The efficacy of CCC-A and ∆CCC in the diagnosis of primary malignant hepatic tumors was determined by plotting receiver operating characteristic (ROC) curves. We also compared the effects of MRS on the diagnostic accuracy of liver-occupying lesions with junior and experienced radiologist. RESULTS: A significant increase in mean CCC-A was observed in malignant tumors compared with benign tumors. The ROC curve showed ∆CCC had a high discriminatory ability in diagnosing primary malignant hepatic tumors with a sensitivity and specificity of 94.3 and 93.3 %, respectively. The ∆CCC area under the curve (AUC) was 0.97 that was larger than that of both junior and experienced radiologist, while the significantly statistical difference was only obtained between ∆CCC and junior radiologist (P = 0.01). CONCLUSION: (1)H MRS with ∆CCC demonstrates good efficacy in diagnosing primary malignant hepatic tumors. The technique improves the accuracy of diagnosing liver-occupying lesions, particularly for junior radiologists.
format Online
Article
Text
id pubmed-4994245
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49942452016-08-24 Diagnostic value of 3.0T (1)H MRS with choline-containing compounds ratio (∆CCC) in primary malignant hepatic tumors Zhang, Li Zhao, Xinming Ouyang, Han Wang, Shuang Zhou, Chunwu Cancer Imaging Research Article BACKGROUND: The purpose of this study was to investigate the diagnostic value of 3.0-T (1)H magnetic resonance spectroscopy ((1)H MRS) in primary malignant hepatic tumors and to compare the effects of (1)H MRS on the diagnostic accuracy of liver-occupying lesions between junior and experienced radiologists. METHODS: This study included 50 healthy volunteers and 40 consecutive patients (50 lesions). Informed consent was obtained from each subject. Images were obtained on clinical whole-body 3.0-T MR system. Point -Resolved Spectroscopy was used to obtain the spectroscopy image. All conventional images were reviewed blindly by junior radiologist and experienced radiologist, respectively. The choline-containing compounds peak area (CCC-A) was measured with SAGE software, and the choline-containing compound ratio (∆CCC) was calculated. The efficacy of CCC-A and ∆CCC in the diagnosis of primary malignant hepatic tumors was determined by plotting receiver operating characteristic (ROC) curves. We also compared the effects of MRS on the diagnostic accuracy of liver-occupying lesions with junior and experienced radiologist. RESULTS: A significant increase in mean CCC-A was observed in malignant tumors compared with benign tumors. The ROC curve showed ∆CCC had a high discriminatory ability in diagnosing primary malignant hepatic tumors with a sensitivity and specificity of 94.3 and 93.3 %, respectively. The ∆CCC area under the curve (AUC) was 0.97 that was larger than that of both junior and experienced radiologist, while the significantly statistical difference was only obtained between ∆CCC and junior radiologist (P = 0.01). CONCLUSION: (1)H MRS with ∆CCC demonstrates good efficacy in diagnosing primary malignant hepatic tumors. The technique improves the accuracy of diagnosing liver-occupying lesions, particularly for junior radiologists. BioMed Central 2016-08-22 /pmc/articles/PMC4994245/ /pubmed/27549094 http://dx.doi.org/10.1186/s40644-016-0082-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zhang, Li
Zhao, Xinming
Ouyang, Han
Wang, Shuang
Zhou, Chunwu
Diagnostic value of 3.0T (1)H MRS with choline-containing compounds ratio (∆CCC) in primary malignant hepatic tumors
title Diagnostic value of 3.0T (1)H MRS with choline-containing compounds ratio (∆CCC) in primary malignant hepatic tumors
title_full Diagnostic value of 3.0T (1)H MRS with choline-containing compounds ratio (∆CCC) in primary malignant hepatic tumors
title_fullStr Diagnostic value of 3.0T (1)H MRS with choline-containing compounds ratio (∆CCC) in primary malignant hepatic tumors
title_full_unstemmed Diagnostic value of 3.0T (1)H MRS with choline-containing compounds ratio (∆CCC) in primary malignant hepatic tumors
title_short Diagnostic value of 3.0T (1)H MRS with choline-containing compounds ratio (∆CCC) in primary malignant hepatic tumors
title_sort diagnostic value of 3.0t (1)h mrs with choline-containing compounds ratio (∆ccc) in primary malignant hepatic tumors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994245/
https://www.ncbi.nlm.nih.gov/pubmed/27549094
http://dx.doi.org/10.1186/s40644-016-0082-4
work_keys_str_mv AT zhangli diagnosticvalueof30t1hmrswithcholinecontainingcompoundsratiocccinprimarymalignanthepatictumors
AT zhaoxinming diagnosticvalueof30t1hmrswithcholinecontainingcompoundsratiocccinprimarymalignanthepatictumors
AT ouyanghan diagnosticvalueof30t1hmrswithcholinecontainingcompoundsratiocccinprimarymalignanthepatictumors
AT wangshuang diagnosticvalueof30t1hmrswithcholinecontainingcompoundsratiocccinprimarymalignanthepatictumors
AT zhouchunwu diagnosticvalueof30t1hmrswithcholinecontainingcompoundsratiocccinprimarymalignanthepatictumors